Critical issues in pleural fluid examinations: laboratory parameters, tumour markers and cytological methods

N. Schoenfeld

Source: Eur Respir Mon; 2002: 22: 110–119
Journal Issue: Pleural Diseases
Disease area: Respiratory infections, Thoracic oncology

PDF journal article, handout or slides

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Schoenfeld. Critical issues in pleural fluid examinations: laboratory parameters, tumour markers and cytological methods. Eur Respir Mon; 2002: 22: 110–119

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Diagnostic approach in a patient with pleural effusion
Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=131
Year: 2002

Prognostic features of residual pleural thickening in parapneumonic pleural effusions
Source: Eur Respir J 2003; 21: 952-955
Year: 2003



Incidence and aetiology of eosinophilic pleural effusion
Source: Eur Respir J 2009; 34: 1111-1117
Year: 2009



Cytology of pleural fluid versus histopathology of the pleura in the diagnosis of malignant pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 775s
Year: 2006

Differential diagnosis of pleural effusion based upon the cytoanalysis of the pleural fluid
Source: Eur Respir J 2006; 28: Suppl. 50, 455s
Year: 2006

Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019

Treatment of parapneumonic pleural effusion and empyema: conservative view
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=199
Year: 2004

Biopsy techniques in the diagnosis of pleural diseases
Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=120
Year: 2002

Utility of pleural fluid glucose measurement in TB pleural effusions.
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020


Procalcitonin in pleural fluid: A new tool for the diagnosis of empyema and parapneumonic pleural effusions?
Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections
Year: 2011

Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010


Surgical problems with the malignant pleural space
Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis
Year: 2006


Pleural fluid IL-6 levels in the identification of the complicated parapneumonic pleural effusion
Source: Annual Congress 2008 - Pleural effusion
Year: 2008

Pleural fluid procalcitonin levels in identifying pleural effusions due to infection
Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Year: 2009


Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020



Is ²blind² pleural biopsy still of value in tuberculous effusions?
Source: Annual Congress 2008 - Diagnosis of tuberculosis: problems and perspectives
Year: 2008

The Abrams pleural biopsy is still useful in the diagnosis of pleural effusions
Source: Annual Congress 2009 - Pleural diseases
Year: 2009


Infectious pleural effusions
Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=204
Year: 2002

Evaluation of pleural fluid clot histology in the diagnosis of pleural malignancy
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008